RecruitingNCT07281755

Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction

Sponsor

Northumbria University

Enrollment

60 participants

Start Date

Aug 8, 2025

Study Type

OBSERVATIONAL

Conditions

Parkinson Disease (PD)

Summary

The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is using wearable sensors worn on the body to objectively measure how Parkinson's disease affects movement and balance over time, with the goal of predicting who is at risk of falling. **You may be eligible if...** - You have been diagnosed with Parkinson's disease by a movement disorder specialist - Your Parkinson's is at stage I, II, or III (mild to moderate) - You are able to walk and stand without assistance for at least 2 minutes - You can travel to Northumbria University in Newcastle for study visits **You may NOT be eligible if...** - You have another neurological condition (such as stroke, Alzheimer's, multiple sclerosis, or Huntington's disease) - Your cognitive score (MoCA test) is below 21 - You have had a lower limb injury in the past 6 weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.